Scientists at Cardiff University have found that aspirin can help treat certain types of cancer. This was announced in a press release on MedicalXpress.
The researchers analyzed data from studies that involved a total of 120,000 patients with bowel, breast, or prostate cancer who took low-dose aspirin and 400,000 who did not. It turned out that taking an antipyretic increased the patient's survival rate by 20-30 percent.
With regard to side effects, only a few patients experienced serious bleeding in the gastrointestinal tract. Their number was no more than the number of those people who did not use aspirin, but also suffered from stomach hemorrhages for other reasons.
Scientists note that the results suggesting the possible benefits of aspirin are obtained from observational studies and cannot be used to identify causation. However, they provide additional evidence of the effectiveness of the pain reliever for the prevention and treatment of malignant tumors.